EXELIXIS, INC.·4

Feb 19, 8:32 PM ET

POSTE GEORGE 4

4 · EXELIXIS, INC. · Filed Feb 19, 2025

Insider Transaction Report

Form 4
Period: 2025-02-14
POSTE GEORGE
Director
Transactions
  • Sale

    Common Stock

    2025-02-14$34.74/sh15,874$551,463169,020 total
  • Exercise/Conversion

    Option (right to buy)

    2025-02-1415,8740 total
    Exercise: $20.50From: 2018-05-24Exp: 2025-05-23Common Stock (15,874 underlying)
  • Exercise/Conversion

    Common Stock

    2025-02-14$20.50/sh+15,874$325,417184,894 total
Footnotes (3)
  • [F1]Includes 18,838 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
  • [F2]Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $34.70 to $34.82. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
  • [F3]The option, representing the right to purchase a total of 15,874 shares of Common Stock, became fully exercisable on May 24, 2018.

Documents

1 file
  • 4
    wk-form4_1740015121.xmlPrimary

    FORM 4